How much redundant work is taking place because we are not aware what our colleagues have already solved or failed at? Yesterday there were 77 active trials for Hydroxychloroquine — and we know exactly why. Why lock out the science and let tweets drive clinical trials? 2/3
-
-
Show this thread
-
I am with you -- patient safety first! But most scientist have login credentials to BioArxiv—stay true to your mission by creating a login-based COVID-19 list. 3/4
Show this thread
End of conversation
New conversation -
-
-
My read is that they are requiring experimental verification, not peer review per se
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
How ironic! Commercial editorials going open access for COVID-19 papers and preprint servers asking for peer-review
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
That’s what we learnt yesterday and shocked to be honest. It’s nonsense not to publish, not even “publish” but posting, in silico results without experiment!! According to this perspective they shouldn’t post in vitro results as well!
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
It’s nonsense at all and against the sprit of preprints...
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Sad! Will you submit this on arXiv?
- End of conversation
New conversation -
-
-
I also got the same response. After removing the drug prediction component, I resubmitted and they took it.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
This is seriously disappointing! Are in silico papers banned on medrxiv too?
-
A few years ago J Med Chem made a decision that they wouldn’t publish any purely in silico papers with zero experimental validation. This was the right decision because they were getting flooded with a huge amount of cheap, purely computational riffraff.
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.